What does HEMATECH CONSULTANTS do?

HEMATECH CONSULTANTS is an accounting firm in Pajottegem. Private Limited, started on 27 May 1991, 1 establishment.

What is the address of HEMATECH CONSULTANTS?

The registered office of HEMATECH CONSULTANTS is located at Oud-Klooster(HN) 2, 1540 Pajottegem.

Is HEMATECH CONSULTANTS still active?

Yes. According to the CBE (30 October 2026) HEMATECH CONSULTANTS is active, legal situation “Normale toestand”, started on 27 May 1991.

Is HEMATECH CONSULTANTS registered on Peppol?

Yes, HEMATECH CONSULTANTS is registered on the Peppol network with ID 0208:0444295137.

What is the enterprise number of HEMATECH CONSULTANTS?

The enterprise number of HEMATECH CONSULTANTS is BE0444295137.

When was HEMATECH CONSULTANTS founded?

HEMATECH CONSULTANTS was founded on 27 May 1991.

Who are the directors of HEMATECH CONSULTANTS?

According to the 2025 annual accounts, the directors of HEMATECH CONSULTANTS are: Eric Luc Silvert.

Is HEMATECH CONSULTANTS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 May 1991; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did HEMATECH CONSULTANTS make in 2025?

HEMATECH CONSULTANTS recorded a loss after taxes of € 2,133 in financial year 2025.

What is the revenue of HEMATECH CONSULTANTS?

As a small company, HEMATECH CONSULTANTS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -2,042.

HEMATECH CONSULTANTS (Private Limited) - Pajottegem

Dossier HEMATECH CONSULTANTS, printed on 30 October 2026 from databakkes.be/en/0444295137/hematech-consultants. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

HEMATECH CONSULTANTS from Pajottegem, company number BE0444295137, closed financial year 2025 with a result of € -2,133 after tax. For that financial year HEMATECH CONSULTANTS recorded a gross margin of € -2,042 and equity of € 47,963. Compared with financial year 2024, the result moved from € -1,663 to € -2,133. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2026.

What it is worth Healthy

€ 47,963

▼ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -2,133

▼ 28 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 46,244

▲ 194% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 27,963.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -782 Gross margin 2022: € -782 First fiscal year in the series	€ -1,526 Gross margin 2023: € -1,526 ▼ € 744 vs 2022 (€ -782) Unfavourable step	€ -1,596 Gross margin 2024: € -1,596 ▼ € 70 vs 2023 (€ -1,526) Unfavourable step	€ -2,042 Gross margin 2025: € -2,042 ▼ € 446 vs 2024 (€ -1,596) Unfavourable step	▼ € 446
Profit after taxes	€ -1,319 Profit after taxes 2022: € -1,319 First fiscal year in the series	€ -1,579 Profit after taxes 2023: € -1,579 ▼ € 260 vs 2022 (€ -1,319) Unfavourable step	€ -1,663 Profit after taxes 2024: € -1,663 ▼ € 84 vs 2023 (€ -1,579) Unfavourable step	€ -2,133 Profit after taxes 2025: € -2,133 ▼ € 470 vs 2024 (€ -1,663) Unfavourable step	▼ € 470
Equity	€ 53,337 Equity 2022: € 53,337 First fiscal year in the series	€ 51,758 Equity 2023: € 51,758 ▼ 3% vs 2022 (€ 53,337) Unfavourable step	€ 50,095 Equity 2024: € 50,095 ▼ 3% vs 2023 (€ 51,758) Unfavourable step	€ 47,963 Equity 2025: € 47,963 ▼ 4% vs 2024 (€ 50,095) Unfavourable step	▼ 4%
Total debts	€ 312 Total debts 2022: € 312 First fiscal year in the series	€ 312 Total debts 2023: € 312 Unchanged (€ 312) Unchanged	€ 349 Total debts 2024: € 349 ▲ 12% vs 2023 (€ 312) Unfavourable step	€ 312 Total debts 2025: € 312 ▼ 11% vs 2024 (€ 349) Favourable step	▼ 11%
Cash	€ 18,912 Cash 2022: € 18,912 First fiscal year in the series	€ 17,333 Cash 2023: € 17,333 ▼ 8% vs 2022 (€ 18,912) Unfavourable step	€ 15,707 Cash 2024: € 15,707 ▼ 9% vs 2023 (€ 17,333) Unfavourable step	€ 46,244 Cash 2025: € 46,244 ▲ 194% vs 2024 (€ 15,707) Favourable step	▲ 194%
Retained profit	€ 33,337 Retained profit 2022: € 33,337 First fiscal year in the series	€ 31,758 Retained profit 2023: € 31,758 ▼ 5% vs 2022 (€ 33,337) Unfavourable step	€ 30,095 Retained profit 2024: € 30,095 ▼ 5% vs 2023 (€ 31,758) Unfavourable step	€ 27,963 Retained profit 2025: € 27,963 ▼ 7% vs 2024 (€ 30,095) Unfavourable step	▼ 7%
Balance sheet total	€ 53,649 Balance sheet total 2022: € 53,649 First fiscal year in the series	€ 52,070 Balance sheet total 2023: € 52,070 ▼ 3% vs 2022 (€ 53,649) Unchanged	€ 50,445 Balance sheet total 2024: € 50,445 ▼ 3% vs 2023 (€ 52,070) Unchanged	€ 48,275 Balance sheet total 2025: € 48,275 ▼ 4% vs 2024 (€ 50,445) Unchanged	▼ 4%

Key figures of HEMATECH CONSULTANTS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to HEMATECH CONSULTANTS?

What happened at HEMATECH CONSULTANTS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 30, 2026 New annual accounts for financial year 2025: loss of € 2,133. Source: NBB ↗
1997 Eric Luc Silvert became a director. NBB
Nov 14, 1991 New establishment in Pajottegem. KBO
May 27, 1991 Start of the company according to the CBE. KBO

In short

From € 1,319 loss in 2022 to € 2,133 loss in 2025.

Original PDFs at the National Bank ↗

Management

SILVERT MEDICAL 97%

The stake of SILVERT MEDICAL comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

HEMATECH CONSULTANTS

Behind HEMATECH CONSULTANTS is Eric Luc Silvert. The shares are held by SILVERT MEDICAL (97%).

Directors

According to the 2025 annual accounts

Eric Luc Silvert

Director

Also active at: SILVERT MEDICAL

since 1997

Shareholders

SILVERT MEDICAL

97%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Oud-Klooster(HN) 2

1540 Pajottegem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

SILVERT MEDICAL same network

€ 262,778 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0444.295.137

VAT number

BE 0444.295.137

Registered office

Oud-Klooster(HN) 2, 1540 Pajottegem

Names & denominations

HEMATECH CONSULTANTS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

27 May 1991

Peppol

Active · Active since 8 Jul 2025

Activities · NACE

Overige fiscale dienstverlening

Boekhouders

Boekhouders en boekhouders-fiscalisten

View on CBE Public ↗ Annual accounts (NBB) ↗

HEMATECH CONSULTANTS

Warning lights

Financials

What happened to HEMATECH CONSULTANTS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions